ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 59 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 592.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $251,000 | -84.1% | 405,474 | -66.6% | 0.00% | – |
Q3 2018 | $1,579,000 | -3.6% | 1,215,141 | +0.1% | 0.00% | – |
Q2 2018 | $1,638,000 | -13.1% | 1,213,341 | -6.7% | 0.00% | – |
Q1 2018 | $1,885,000 | -2.5% | 1,299,963 | +51.3% | 0.00% | – |
Q4 2017 | $1,934,000 | -32.1% | 859,260 | +2.6% | 0.00% | – |
Q3 2017 | $2,847,000 | +8.6% | 837,261 | +13.4% | 0.00% | – |
Q2 2017 | $2,622,000 | -6.2% | 738,535 | -10.2% | 0.00% | – |
Q1 2017 | $2,796,000 | -15.1% | 822,244 | +14.9% | 0.00% | – |
Q4 2016 | $3,293,000 | +19.1% | 715,756 | +9.7% | 0.00% | – |
Q3 2016 | $2,766,000 | +134.2% | 652,260 | +32.5% | 0.00% | – |
Q2 2016 | $1,181,000 | -44.1% | 492,261 | +9.6% | 0.00% | – |
Q1 2016 | $2,112,000 | +19.2% | 449,253 | -0.3% | 0.00% | – |
Q4 2015 | $1,772,000 | -99.0% | 450,753 | -91.9% | 0.00% | -100.0% |
Q3 2015 | $182,081,000 | +5643.9% | 5,586,232 | +710.9% | 0.01% | – |
Q2 2015 | $3,170,000 | -7.5% | 688,932 | +35.5% | 0.00% | – |
Q1 2015 | $3,427,000 | – | 508,466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 5,292,156 | $11,907,000 | 1.66% |
Northeast Financial Consultants Inc | 732,265 | $1,647,000 | 0.55% |
AJ WEALTH STRATEGIES, LLC | 29,624 | $67,000 | 0.02% |
Family Management Corp | 10,424 | $23,000 | 0.02% |
Virtu Financial LLC | 71,588 | $161,000 | 0.01% |
Poehling Capital Management, INC. | 2,802 | $6,000 | 0.01% |
Founders Capital Management | 2,000 | $5,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $333,000 | 0.00% |
WEDBUSH SECURITIES INC | 11,000 | $25,000 | 0.00% |
THRIVENT FINANCIAL FOR LUTHERANS | 298,303 | $671,000 | 0.00% |